ResearcherSapporo Medical UniversityActive in the last 2 years
Makoto Yoshida
Matched on ORCID iD 0009-0001-9892-6412; OpenAlex author ID A5106185941. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 4
- Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter… Co-author DOI 10.1002/ags3.70001↗
- Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. Co-author DOI 10.1111/cas.16101↗
- FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Co-author DOI 10.1097/mpa.0000000000001462↗
- Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. Co-author DOI 10.1371/journal.pone.0039545↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kohichi Takada · 3 shared papers, 2012–2024 · strength 0.31
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. DOI 10.1097/mpa.0000000000001462↗
- Paper Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. DOI 10.1371/journal.pone.0039545↗
- Masayoshi Kobune · 3 shared papers, 2012–2024 · strength 0.31
- Paper Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. DOI 10.1111/cas.16101↗
- Paper FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells. DOI 10.1097/mpa.0000000000001462↗
- Paper Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. DOI 10.1371/journal.pone.0039545↗
- Tomohiro Kubo · 1 shared paper, 2024 · strength 0.19
- Takashi Kojima · 1 shared paper, 2024 · strength 0.19
- Joji Muramatsu · 1 shared paper, 2024 · strength 0.19
- Takumi Konno · 1 shared paper, 2024 · strength 0.19
- Yosuke Inoue · 1 shared paper, 2025 · strength 0.17
- So Yamaki · 1 shared paper, 2025 · strength 0.17
- Sohei Satoi · 1 shared paper, 2025 · strength 0.17
- Yuki Homma · 1 shared paper, 2025 · strength 0.17
- Tetsuya Ikemoto · 1 shared paper, 2025 · strength 0.17
- Yasunari Kawabata · 1 shared paper, 2025 · strength 0.17
- Katsuhisa Hirano · 1 shared paper, 2025 · strength 0.17
- Joji Kitayama · 1 shared paper, 2025 · strength 0.17
- Masamichi Mizuma · 1 shared paper, 2025 · strength 0.17
- Toshimichi Asano · 1 shared paper, 2025 · strength 0.17
- Atsushi Oba · 1 shared paper, 2025 · strength 0.17
- Yasutoshi Kimura · 1 shared paper, 2025 · strength 0.17
- Daisuke Hashimoto · 1 shared paper, 2025 · strength 0.17
- Tomohisa Yamamoto · 1 shared paper, 2025 · strength 0.17
- Yuko Mataki · 1 shared paper, 2025 · strength 0.17
- Hiromitsu Maehira · 1 shared paper, 2025 · strength 0.17
- Ippei Matsumoto · 1 shared paper, 2025 · strength 0.17
- Yasuhiro Kodera · 1 shared paper, 2025 · strength 0.17
- Michiaki Unno · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.